Hemlibra (emicizumab) Update
A statement has been issued by Roche (see below) with regards to the deaths of five individuals with haemophilia with inhibitors who passed away while receiving Hemlibra (previously known as Emicizumab). One of these deaths was previously known as it had been reported previously as part of the clinical trial for the therapy. Three of …